Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...

Quarterly Adjusted EBITDA -- $4.9 million, a $6.3 million improvement from negative $1.4 million in the prior year, with a ...

On Thursday, a federal judge granted a request by environmental groups to disclose records generated by the Trump Administration ...

Hyderabad: Deputy chief minister Bhatti Vikramarka Mallu on Saturday directed officials of the welfare departments to complete hostels that are alread.

It's not too late to build your accounting firm's quality management system, and it doesn't have to be overwhelming.

NCCN now recognizes BCG-unresponsive papillary-only NMIBC as eligible for nogapendekin plus BCG, broadening access beyond the ...

Achieved over $50 million of cash receipts, including $33.6 million in royalties and $16.9 million milestones, in full year 2025 • Total receipts increased 9% with royalties up 68% versus full year ...

The Dr. Martin Luther King, Jr. Community Center has plans to open a satellite food pantry in Newport’s North End this spring ...

Kyntra Bio(NASDAQ:KYNB) reported that its rebranding, asset sale, and debt payoff have shifted the company’s financial structure and enabled a clinical focus on oncology and rare disease. Management ...

Officials with the FDA have released a draft guidance that aims to help drug developers validate new approach methodologies (NAMs) that can be used in place of animal testing. Based on human-centric ...

A proposal to build a hydroelectric power plant near the Red Rock Canyon National Conservation Area won preliminary approval from federal regulators earlier this month. The Desert Bloom Project is a ...

Welcome to the Biofrontera Inc. Fourth Quarter and Full Year 2025 Financial Results and Business Update Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now ...